BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Response to oxidative stress
,
Influenza
,
Intestine
,
Metabolism of nitric oxide
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
bindings of glibenclamide
Summary
General Info
Curated Studies
Most Correlated Studies
There were no matches for bindings of glibenclamide
Explore Curated Studies Results
Literature
Most Relevant Literature
Importance of the Kir6.2 N-terminus for the interaction of glibenclamide and repaglinide with the pa…
Glibenclamide enhances neurogenesis and improves long-term functional recovery after transient focal…
The R230C variant of the ATP binding cassette protein A1 (ABCA1) gene is associated with a decreased…
Nuciferine stimulates insulin secretion from beta cells-an in vitro comparison with glibenclamide.
Glibenclamide inhibits cell growth by inducing G0/G1 arrest in the human breast cancer cell line MDA…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Efficacy and Safety Study of Sulfonylureas in Neonatal Diabetes Mellitus
Glibentek in Patients With Neonatal Diabetes Secondary to Mutations in K+-ATP Channels
Sulphonylurea Receptor Mutation and Responsiveness to Gliclazide - a Pilot Proof of Concept, Randomi…
R230C and C230C Variants of ABCA1 and Glyburide Response
Effect of Bosentan on Skin Fibrosis in Patients With Systemic Sclerosis
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ